Real Brands, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLBD research report →
About the company
Real Brands, Inc. specializes in the comprehensive process of hemp-derived cannabidiol (CBD), from the extraction of CBD oil and isolate, through their wholesale distribution, to the manufacturing and retail of a diverse range of CBD-infused consumer products. Their extensive product line includes topical creams, gels, and lotions, cosmetic items, ingestible options like tinctures, oils, and capsules, as well as vape cartridges and oral sprays.
- CEO
- Thomas Kidrin
- IPO
- 2000
- Employees
- 1
- HQ
- North Providence, RI, US
Price Chart
- Market Cap
- $26.91K
- P/E
- -0.02
- P/S
- 0.45
- P/B
- -0.02
- EV/EBITDA
- -0.84
- Div Yield
- 0.00%
- Gross Margin
- -41.61%
- Op Margin
- -1970.13%
- Net Margin
- -2203.36%
- ROE
- 129.53%
- ROIC
- 481.66%
- Revenue
- $60.45K · 443.01%
- Net Income
- $-1,332,000 · -47.03%
- EPS
- $-0.00 · -66.67%
- Op Income
- $-1,191,000
- FCF YoY
- 74.07%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.93
- Avg Volume
- 845
Get TickerSpark's AI analysis on RLBD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 24, 21 | Turning Point Brands, Inc. | other | 0 |
| Sep 24, 21 | Ryan Christopher John | other | 0 |
| Sep 24, 21 | KIDRIN THOMAS | other | 0 |
| Sep 24, 21 | CHRISTOS PETER N | other | 0 |
| Jul 1, 20 | CHRISTOS PETER N | other | 6,143,628 |
| Sep 24, 21 | TOBOROFF LEONARD | other | 0 |
| Jul 1, 20 | TOBOROFF LEONARD | other | 6,143,628 |
| May 1, 21 | Dobbins James Wells | other | 46,077,210 |
| Jan 2, 08 | Spitalny Brett S. | other | 3,000,000 |
| Feb 6, 08 | Spitalny Brett S. | other | 600,000 |
Our RLBD coverage
Recent articles, reports, and earnings notes.
No research on RLBD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate RLBD report →Similar companies
Peers in the same neighborhood.